Loading clinical trials...

Relationship Between Central Sensitization Levels and Treatment Outcomes in Frozen Shoulder Treatment | Clinical Trials | Clareo Health

COMPLETED

Relationship Between Central Sensitization Levels and Treatment Outcomes in Frozen Shoulder Treatment

Relationship Between Central Sensitization Levels and Treatment Outcomes in Patients Diagnosed With Frozen Shoulder and Undergoing Intra-Articular Injection

NCT07124689•Sultan 1. Murat State Hospital

View on ClinicalTrials.gov

Summary

The aim of this study was to evaluate the relationship between treatment outcomes and central sensitization levels in patients who received intra-articular injections for frozen shoulder.

Eligibility

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Being between 18 and 75 years of age
•More than one-third of the active and passive movement of the painful shoulder is limited in two or more planes
•Having pain and limited movement in the shoulder for 3-12 months

Exclusion Criteria

•Having bilateral shoulder pain
•Patients with incomplete study data
•Having cervical radiculopathy
•Having a predominant central sensitization syndrome (such as fibromyalgia, chronic fatigue syndrome)
•Patients taking antidepressants or anticonvulsants that may affect central sensitization
•Having a history of rheumatological disease
•Having a history of active malignancy
•Patients receiving treatment for active psychiatric disorders
•Having a history of trauma and/or surgery in the same shoulder region
•Patients who received local shoulder injections and/or physical therapy within the last 3 months
+2 more criteria

Locations (1)

Sultan 1. Murat State Hospital

Edirne, Turkey (Türkiye)

Key Dates

Start Date

August 9, 2025

Primary Completion Date

November 15, 2025

Completion Date

December 15, 2025

Last Updated

December 31, 2025

Enrollment

ACTUAL participants

Conditions

Frozen ShoulderCentral SensitisationTreatmentIntra-Articular InjectionShoulder Pain

Interventions

Treatment outcome

OTHER

A Trial of Chinese Traditional Medicine Combining With Intradermal Acupuncture for Treating Precocious Puberty

NCT06510764

Precocious PubertyTreatment+2 more

View study

RECRUITINGPHASE1

Venetoclax Basket Trial for High Risk Hematologic Malignancies

NCT05292664

Myelodysplastic Syndromes, de NovoMyelodysplastic Syndromes, Secondary+9 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 31, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Relationship Between Central Sensitization Levels and Treatment Outcomes in Frozen Shoulder Treatment

Inclusion Criteria

Exclusion Criteria

A Trial of Chinese Traditional Medicine Combining With Intradermal Acupuncture for Treating Precocious Puberty

Venetoclax Basket Trial for High Risk Hematologic Malignancies

Effect Clomiphene vs Clomiphene Along With Pioglitazone on Ovarian Stimulation Rate

Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis

University of Iowa Interventional Psychiatry Service Patient Registry

Virtual Reality-Based Mindfulness as an Adjunct to Treatment as Usual in Treatment-Resistant Depression